Genetics and Biochemistry News

Researching her own disease

When senior genetics major Sofia Willey was in middle school, she began having abnormally intense joint pain, something doctors attributed to the rigor of competitive gymnastics and her 20 hour-a-week training schedule.

At first, doctors diagnosed her with hip dysplasia, but that didn’t account for the hypermobility symptoms, scarring and low bone growth. Her doctor then suggested Sofia may have Ehlers-Danlos Syndrome (EDS), specifically the hypermobile subtype. EDS is a rare genetic disorder that affects the connective tissue and can cause weak joints, affecting 1 in 5,000 people.

“I didn’t understand what was happening to me, and no one around me did either.”

Doctors’ limited knowledge of the disorder is due in part to the EDS being under-researched. This has inspired Sofia to pursue a degree in genetics and focus on research while in college.

“It becomes a lot of explaining your own problems to your doctor so they can prescribe or help you find what you need.”

This summer Sofia worked with the Norris Lab at the Medical University of South Carolina on a project related to the complement system and its biological importance in hEDS. Dr. Russell Norris a professor in the Department of Regenerative Medicine and Cell Biology. Norris lab is one of the preeminent labs researching EDS.

Sofia’s specific research aims at finding a diagnostic tool that could use specific protein levels in the blood to determine if a patient has EDS. She focused on changes in the immune system of patients with EDS compared to those without the disease, finding a few significant proteins that had different levels in subjects with EDS than in those without.

Sofia says her time in the Norris lab, which also included patient education, has helped her better understand her disease and problems in her own body. She hopes to change patients’ lives through knowledge of under-recognized diseases.

Read more in the Clemson News article.

Ph.D. student’s internship broadens career path

Jessica Aycock is a second year Ph.D. student in Dr. Stephen Dolan’s lab housed in the Eukaryotic Pathogens Innovation Center (EPIC) at Clemson University. This fall she had the opportunity to intern at IDeA National Resource for Quantitative Proteomics at the Winthrop P. Rockefeller Cancer Institute at University of Arkansas for Medical Sciences (UAMS) in Little Rock, AK.

The IDeA National Resource for Quantitative Proteomics Internship program is designed to provide a unique opportunity for the next generation of scientists to explore an alternative career option in biomedical research by gaining experience in a national resource and core facility environment. Interns are encouraged to bring proteomics samples related to their project, enabling them to work on their own research while they are interning.

Jessica spent two weeks at IDeA National Resource for Quantitative Proteomics gaining a unique hands-on research experience which included managing the entire behind the scenes proteomics workflow – sample prep, mass spectrometry and downstream bioinformatics processing – on her own Ph.D. research samples.

“Not only did I deepen my understanding of my own research, but the experience also broadened my perspective of career opportunities beyond traditional paths.”

In addition, Jessica learned the ins and outs of mass spectrometers including instrumentation, operation and contribution to data acquisition. She also had the chance to explore career options outside of industry and academia, learning how a national core facility functions.

“Learning the intricacies of proteomics through participating in the IDeA National Resource for Quantitative Proteomics internship was an amazing, eye-opening experience. Moving forward, I plan to use these insights to advance my research in the Dolan Lab and explore new directions in the field of proteomics!”

IDeA National Resource for Quantitative Proteomics provides unmatched and cost-effective access to state-of-the-art quantitative proteomics platforms and education, outreach and training opportunities that will increase the capacity of National Institutes of Health-funded investigators to perform cutting-edge biomedical research.